Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Deuruxolitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sun Pharma Presents LEQSELVI™ Data for Alopecia Areata
    Sun Pharma Presents LEQSELVI™ Data for Alopecia Areata

    25 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sun-pharma-presents-leqselvi-deuruxolitinib-data-highlighting-clinical-efficacy--durability-for-treatment-of-alopecia-areata-at-the-2024-fall-clinical-dermatology-conference-302287597.html

    PR NEWSWIRE
    25 Oct 2024
    Share Share
    Sun Pharma Presents Data At EADV Congress
    Sun Pharma Presents Data At EADV Congress

    26 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sun-pharma-presents-new-clinical-efficacy-and-safety-data-in-severe-dermatological-conditions-at-the-2024-european-academy-of-dermatology-and-venereology-eadv-congress-302259872.html

    PR NEWSWIRE
    26 Sep 2024
    Share Share
    Sun Pharma's drug to treat alopecia areata gets USFDA nod
    Sun Pharma's drug to treat alopecia areata gets USFDA nod

    26 Jul 2024

    // ECONOMICSTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharmas-drug-to-treat-alopecia-areata-gets-usfda-nod/articleshow/112032939.cms

    ECONOMICSTIMES
    26 Jul 2024
    Share Share
    US FDA halts India's Sun Pharma trials on dermatological drug
    US FDA halts India's Sun Pharma trials on dermatological drug

    02 May 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/sun-pharma-says-us-fda-puts-partial-clinical-hold-its-dermatological-drug-2023-05-02/

    REUTERS
    02 May 2023
    Share Share
    Phase 3 Data at AAD 2023 Show Deuruxolitinib Improved Scalp Hair Regrowth
    Phase 3 Data at AAD 2023 Show Deuruxolitinib Improved Scalp Hair Regrowth

    18 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/late-breaking-phase-3-data-at-aad-2023-show-oral-investigational-medicine-deuruxolitinib-significantly-improved-scalp-hair-regrowth-in-alopecia-areata-301775606.html

    PR NEWSWIRE
    18 Mar 2023
    Share Share
    Concert persuades FDA to keep alopecia therapy breakthrough tag
    Concert persuades FDA to keep alopecia therapy breakthrough tag

    15 Feb 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/concert-persuades-fda-keep-breakthrough-tag-alopecia-therapy-despite-lillys-arrival

    James Waldron FIERCE BIOTECH
    15 Feb 2023
    Share Share